(Q40039898)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

David Putnam

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

C Garrett Rappazzo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Hannah C Watkins

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Cassandra M Guarino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Annie Chau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jody L Lopez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Cynthia A Leifer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Gary R Whittaker

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

29 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

1252-1258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

Influenza vaccines: a moving interdisciplinary field.

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Advances in the development of influenza virus vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

The function of Fcγ receptors in dendritic cells and macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Natural and long-lasting cellular immune responses against influenza in the M2e-immune host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

A universal influenza A vaccine based on the extracellular domain of the M2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Engineered bacterial outer membrane vesicles with enhanced functionality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Delivery of foreign antigens by engineered outer membrane vesicle vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Inhibition of influenza virus infection and hemagglutinin cleavage by the protease inhibitor HAI-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Universal influenza A vaccine: optimization of M2-based constructs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Innate immune response in Th1- and Th2-dominant mouse strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

A "universal" human influenza A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

M2e-Based Universal Influenza A Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective e

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Immune modulation by bacterial outer membrane vesicles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

Use of defined TLR ligands as adjuvants within human vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.01.028

10.1016/J.VACCINE.2016.01.028

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827663%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference